ALKERMES | ALKS - 市值

金融业

USD

USD 4.39B

现金及等价物

USD 511.53M

USD 120.7M

USD 1.52B

USD 662.09M

USD 1.58B

股息收益率

0

USD -65.93M

USD 139.22M

1.8K

EPS每股收益

USD 0

股本和储备

USD 1.81B

USD 375.31M

债务利息支出

USD 25.93M

USD 8.54M

USD 1.48B

USD 7.46B

USD 501K

USD 1.81B

USD -65.93M

普通股股本

USD 167.54M

135.81

USD -61.93M

USD 496.01M

销售和管理费用

USD 196.64M

USD 298.96M

贸易债权人

USD 142.86M

应收帐款人

USD 456.48M

	市值	更改		日
AbbVie	USD 444.6B		59.91B	2026-06
Acadia Pharmaceuticals	USD 4.33B		537M	2026-06
ALKERMES	USD 8.73B		2.85B	2026-06
Amgen	USD 195.44B		5.55B	2026-06
Biogen	USD 31.9B		5B	2026-06
BioMarin Pharmaceutical	USD 11.06B		196M	2026-06
Bristol-Myers Squibb	USD 117.66B		6.17B	2026-06
Coherus Biosciences	USD 172M		19M	2025-12
Eli Lilly	USD 1.13T		260.54B	2026-06
Gilead Sciences	USD 156.86B		16.13B	2026-06
Heron Therapeutics	USD 238M		7M	2025-12
Ionis Pharmaceuticals	USD 13.1B		642M	2026-06
J&J	USD 611.36B		32.21B	2026-06
Malin Corporation	EUR 133.52M		29.05M	2026-08
Merck	USD 317.37B		20.27B	2026-06
Nektar Therapeutics	USD 2.12B		1.26B	2026-03
Neurocrine Biosciences	USD 16.95B		3.7B	2026-06
Otsuka Holdings	JPY 5.87T		111.31B	2026-06
Ovoca Bio	EUR 1.17M		18.38K	2025-12
Pfizer	USD 138.44B		15.37B	2026-06
Regeneron Pharmaceuticals	USD 65.37B		16.31B	2026-06
Vertex Pharmaceuticals	USD 126.07B		12.49B	2026-06